Hypotensive and Angiotensin-Converting Enzyme Inhibitory Activities of Eisenia fetida Extract in Spontaneously Hypertensive Rats

Abstract EN

Objectives.

This study aimed to investigate the antihypertensive effects of an Eisenia fetida extract (EFE) and its possible mechanisms in spontaneously hypertensive rats (SHR rats).

Methods.

Sixteen-week-old SHR rats and Wistar-Kyoto rats (WKY rats) were used in this study.

Rats were, respectively, given EFE (EFE group), captopril (captopril group), or phosphate-buffered saline (PBS) (normal control group and SHR group) for 4 weeks.

ACE inhibitory activity of EFE in vitro was determined.

The systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured using a Rat Tail-Cuff Blood Pressure System.

Levels of angiotensin II (Ang II), aldosterone (Ald), and 6-keto-prostaglandin F1 alpha (6-keto-PGF1α) in plasma were determined by radioimmunoassay, and serum nitric oxide (NO) concentration was measured by Griess reagent systems.

Results.

EFE had marked ACE inhibitory activity in vitro (IC50 = 2.5 mg/mL).

After the 4-week drug management, SHR rats in EFE group and in captopril group had lower SBP and DBP, lower levels of Ang II and Ald, and higher levels of 6-keto-PGF1α and NO than the SHR rats in SHR group.

Conclusion.

These results indicate that EFE has hypotensive effects in SHR rats and its effects might be associated with its ACE inhibitory activity.